Elucidation of allosteric inhibition mechanism of 2-Cys human peroxiredoxin by molecular modeling

J Chem Inf Model. 2012 Dec 21;52(12):3278-83. doi: 10.1021/ci3004495. Epub 2012 Dec 6.

Abstract

We used molecular dynamics (MD) simulations and protein docking to elucidate the mechanism of allosteric inhibition of the human form of peroxiredoxin (Prx), 2-Cys proliferation associated gene (PAG). Beginning by using the rat form of Prx, 2-Cys heme-binding protein as a template, we used homology modeling to find the structure of human 2-Cys PAG, which is in dimeric form. Molecular dynamics simulations showed that the structure of the reduced form of the 2-Cys PAG dimer fluctuates as the two monomers drift away and approach each other. We then used SiteMap to search for binding sites on the surface of this dimer. A binding site between the two monomers was found, and virtual screening with docking was performed to identify a ligand binding to this site. Subsequent MD simulation revealed that with this ligand in the binding site, the dimer structure of 2-Cys PAG becomes stabilized such that two cysteine residues from two monomers, which are partners of a disulfide bond of the oxidized form, remain separated. This mechanism can be used as an allosteric inhibition of Prx as a hydrogen peroxide reducer, the role of which has been studied as an anticancer drug target.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Allosteric Regulation / drug effects
  • Amino Acid Sequence
  • Animals
  • Binding Sites
  • Drug Discovery
  • Enzyme Inhibitors / metabolism*
  • Enzyme Inhibitors / pharmacology*
  • Humans
  • Molecular Docking Simulation*
  • Molecular Dynamics Simulation*
  • Molecular Sequence Data
  • Peroxiredoxins / antagonists & inhibitors*
  • Peroxiredoxins / chemistry*
  • Peroxiredoxins / metabolism
  • Protein Conformation
  • Rats
  • Thermodynamics

Substances

  • Enzyme Inhibitors
  • Peroxiredoxins